Then, we knocked down GADD45g expression in MPN cell lines HEL and SET-2 by lentiviral delivery of shRNAs (shGADD45g-1 and shGADD45g-2) (Fig. 1f–g). The gene discussed is SETD2; the disease is myeloproliferative neoplasm.